The Effects of Western Diet Patterns on Plasma Inflammatory and Cardio Metabolic Health Signatures in Middle-aged Adults
1 other identifier
interventional
21
1 country
1
Brief Summary
The Western diet pattern or standard American diet is a modern dietary pattern that is characterized by high intakes of meat, pre-packaged foods, fried foods, high-fat dairy products, eggs, refined grains etc. When considering the role of saturated fat, it may be prudent to advise limiting all foods that contain saturated fats, including unprocessed/minimally processed meat, eggs, whole dairy in addition to processed, pre-packaged foods; however, this reductionist approach fails to take into account the food matrix and overall diet in which these nutrients are consumed. Epidemiological evidence suggests that increased modern, pre-packaged food consumption is a major risk factor for metabolic disease by promoting inflammation. Based on these data, the investigators hypothesize that the pro-atherogenic effect of the Western diet is caused by the pro-inflammatory effects of consuming large amounts of modern ultra-processed foods, and that consumption of a similar amount of fat from minimally processed beef, poultry, dairy, eggs, as part of an unprocessed diet will positively impact inflammatory markers and lipoprotein profiles of study participants when compared to a diet rich in modern ultra-processed foods.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 7, 2020
CompletedFirst Posted
Study publicly available on registry
February 19, 2020
CompletedStudy Start
First participant enrolled
October 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 21, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 21, 2021
CompletedJuly 13, 2022
January 1, 2022
1.2 years
February 7, 2020
July 11, 2022
Conditions
Outcome Measures
Primary Outcomes (3)
Change in plasma interleukin-6 levels
Plasma interleukin-6 levels will be measured before and after each diet
Baseline, up to 4 weeks.
Change in plasma c-reactive protein levels
Plasma c-reactive protein levels levels will be measured before and after each diet
Baseline, up to 4 weeks.
Change in plasma acylcarnitine profiles
Plasma acylcarnitines profiles levels will be measured before and after each diet
Baseline, up to 4 weeks.
Secondary Outcomes (3)
Change in gut microbiota communities
Baseline, up to 4 weeks.
Energy expenditure
up to 4 weeks.
Change in Neuroinflammation
Baseline, up to 4 weeks.
Study Arms (2)
Traditional Diet
ACTIVE COMPARATORUnprocessed/minimally processed whole foods.
Modern Diet
ACTIVE COMPARATORMulti-ingredient, ultra-processed formulations of the traditional diet.
Interventions
Consuming an traditional whole foods based diet for 4 weeks.
Consuming an processed formulation of the traditional diet for 4 weeks.
Eligibility Criteria
You may qualify if:
- Age ≥35 and ≤60 years;
- BMI ≥25 and ≤35 kg/m2;
- Weight stable in last 3 months (Loss or gain \<4%);
- Consistent physical activity levels;
- Hemoglobin A1C (HbA1C) ≤6.4%;
- Fasting insulin; \<15 µU/mL;
- Fasting plasma glucose concentration \<126 mg/dl;
- Willingness to eat the food provided in this study;
- Subjects must be able to speak and understand English to participate in this study
- Own a smartphone or other mobile device capable of downloading the Garmin Connect app.
You may not qualify if:
- Diagnoses of active malignancy, congestive heart failure, diabetes mellitus, chronic obstructive pulmonary disease, thyroid disease or other metabolic disorders that influence metabolism;
- Evidence of impaired kidney function (Estimated glomerular filtration rate \[eGFR\] \<44 mL/min;
- Regular use of medication that interferes with the measurement of study outcomes as determined by the study team (e.g., NSAIDs, corticosteroids);
- Consuming \>14 drinks per week of \>4 drinks per night twice/week for male; \>7 drinks per week or \>3 drinks per night twice/week for female;
- Use of cigarettes (or other tobacco products) or use of any other (recreational) drug in last 3 months;
- Engaged in high-level competitive exercise (e.g., marathons, triathlons, cycling, weight-lifting competitions etc.)
- Self-reported sleep duration \<5 hours per night;
- Any inflammatory diseases (e.g. asthma, autoimmune diseases, coeliac disease, glomerulonephritis, hepatitis, inflammatory bowel disease, arthritis);
- Use of antibiotics in last 30 days;
- Pregnant or lactating women;
- Eating disorders (e.g., anorexia nervosa, bulimia nervosa, binge eating disorders etc.)
- Psychological disorders (e.g., clinical depression, bipolar disorders etc.);
- Strict dietary patterns (e.g., vegan, carnivore, kosher, low-carb etc.);
- History of stomach or bowel resection (other than appendectomy), gastric bypass or other bariatric weight loss procedure effecting absorption;
- Persons who are not able to grant voluntary informed consent;
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
- North Dakota Beef Commissioncollaborator
Study Sites (1)
Duke University School of Medicine
Durham, North Carolina, 27701, United States
Study Officials
- STUDY DIRECTOR
Stephan van Vliet, PhD
Duke University
- PRINCIPAL INVESTIGATOR
Kim Huffman, MD, PhD
Duke University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- As this is feeding study with two very much different diets, participants and investigators were not blinded. The Core facilities that are analyzing de-identified coded samples and remain blinded to treatments.
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 7, 2020
First Posted
February 19, 2020
Study Start
October 1, 2020
Primary Completion
December 21, 2021
Study Completion
December 21, 2021
Last Updated
July 13, 2022
Record last verified: 2022-01
Data Sharing
- IPD Sharing
- Will not share